Results 181 to 190 of about 73,649 (308)

Prognostic Significance of Circulating Immune Subset Counts in Nasopharyngeal Carcinoma

ImmunoTargets and Therapy
Honghui Xie,1– 3,* Lin Zhang,1,3,4,* Lizhi Chen,5,* Wenchao Zhou,1,6 Lijuan Zhang,1,3 Yong Su,1– 3 Bocheng Li,1,6 Peng Ding,1,6 Yun Xiao,1– 3 Tianzhu Lu,1,2,4,7 Xiaochang Gong,1,2,4,7 Jingao Li1,2,4,7 1NHC Key Laboratory of ...
Xie H, Zhang L, Chen L, Zhou W, Zhang L, Su Y, Li B, Ding P, Xiao Y, Lu T, Gong X, Li J   +11 more
doaj  

A bibliometric analysis of the evolution of nanotechnology research in precision theranostics for nasopharyngeal carcinoma. [PDF]

Discov Nano
Qu TF, Li ZJ, Zhang MM, Lu KK.
europepmc   +1 more source

Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver

Molecular Oncology, Volume 20, Issue 6, Page 1494-1512, June 2026.
Meta‐transcriptome analysis identified FGF19 as a peptide enteroendocrine hormone associated with colorectal cancer prognosis. In vivo xenograft models showed release of FGF19 into the blood at levels that correlated with tumor volumes. Tumoral‐FGF19 altered murine liver metabolism through FGFR4, thereby reducing bile acid synthesis and increasing ...
Jordan M. Beardsley, Michael W. Rohr, Joseph A. Goode, Sai Preethi Nakkina, Jignesh G. Parikh, Deborah A. Altomare   +5 more
wiley   +1 more source

Association Between Nasopharyngeal Carcinoma and Chinese Medicine Constitution: A Meta-Analysis. [PDF]

Cancer Med
Chen SQ, Zi Y, Li WL, Cai YY, Miao GS, Wang HY, Bai MH, Wang J.   +7 more
europepmc   +1 more source

Sinonasal Undifferentiated Carcinoma and Nasopharyngeal-Type Undifferentiated Carcinoma - Two Clinically, Biologically, and Histopathologically Distinct Entities

, 2009
Sinonasal undifferentiated carcinoma (SNUC) is a rare aggressive neoplasm arising in the nasal cavity and paranasal sinuses. Primary sinonasal nasopharyngeal-type undifferentiated carcinoma (PSNPC) is an even rarer tumor that has not been adequately ...
JENG, YUNG-MING;MAO, TSUI-LIEN;HSIAO, CHENG-HSIANG, 鄭永銘;毛翠蓮;蕭正祥   +1 more
core  

Development of a Prediction Model for Progression Risk in High‐Grade Gliomas Based on Habitat Radiomics and Pathomics

Annals of Clinical and Translational Neurology, Volume 13, Issue 6, Page 1141-1153, June 2026.
ABSTRACT Objective To investigate the value of constructing models based on habitat radiomics and pathomics for predicting the risk of progression in high‐grade gliomas. Methods This study conducted a retrospective analysis of preoperative magnetic resonance (MR) images and pathological sections from 72 patients diagnosed with high‐grade gliomas (52 ...
Yuchen Zhu, Yuxi Gong, Weilin Xu, Xingjian Sun, Gefei Jiang, Lei Qiu, Kexin Shi, Mengxing Wu, Yinjiao Fei, Jinling Yuan, Jinyan Luo, Yurong Li, Yuandong Cao, Minhong Pan, Shu Zhou   +14 more
wiley   +1 more source

Micronests in Tumor Stroma is a Prognostic Classifier in Nasopharyngeal Carcinoma. [PDF]

Am J Surg Pathol
Almangush A, Ruuskanen M, Hagström J, Kosma VM, Mäkitie AA, Leivo I.   +5 more
europepmc   +1 more source

A Nanobody‐LNP Platform for Targeting and Relicensing Dendritic Cells for Potent Cancer Immunotherapy

Advanced Science, Volume 13, Issue 34, 19 June 2026.
Plastin‐2 (PLS2) is identified as a dual‐function receptor on DCs that mediates both nanoparticle uptake and immunomodulation. A nanobody‐LNP platform is engineered to integrate antigen delivery with relicensing DCs. The therapeutic strategy elicits potent anti‐tumor T cell responses and leads to significant inhibition of established tumors in vivo ...
Shugang Qin, Zhiying Huang, Hai Huang, Yupei Zhang, Yuting Chen, Xi He, Zhenyi Niu, Zhongzheng Xiang, Chaoyu Zou, Xiangrong Song   +9 more
wiley   +1 more source

Prediction of treatment outcome in nasopharyngeal carcinoma patients. [PDF]

BMC Cancer
Zhou G, Sijtsema NM, Li Y, Zhai T, Xi L, Li J, van der Schaaf A, van Dijk LV, Shi Y, Yang P, Langendijk JA.   +10 more
europepmc   +1 more source

Nasopharyngeal Carcinoma

, 1987
openaire   +2 more sources